Join
Live feed
·
PRReleasevia Quantisnow
Anchiano Therapeutics Ltd. logo

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

ByQuantisnow·Wall Street's wire, on your screen.
ANCN· Anchiano Therapeutics Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANCN (Anchiano Therapeutics Ltd.) and more on Quantisnow.